相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Study of 89Zr-Pembrolizumab PET/CT in Patients With Advanced-Stage Non-Small Cell Lung Cancer
Anna-Larissa N. Niemeijer et al.
JOURNAL OF NUCLEAR MEDICINE (2022)
A Systematic Evaluation of Antibody Modification and 89Zr-Radiolabeling for Optimized Immuno-PET
Sai Kiran Sharma et al.
BIOCONJUGATE CHEMISTRY (2021)
Head-to-head comparison of DFO* and DFO chelators: selection of the best candidate for clinical89Zr-immuno-PET
Marion Chomet et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Radiolabelling and preclinical characterization of 89Zr-Df-radiolabelled bispecific anti-PD-L1/TGF-βRII fusion protein bintrafusp alfa
Ingrid Julienne Georgette Burvenich et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Total-Body PET and Highly Stable Chelators Together Enable Meaningful 89Zr-Antibody PET Studies up to 30 Days After Injection
Eric Berg et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Preparation of Zirconium-89 Solutions for Radiopharmaceutical Purposes: Interrelation Between Formulation, Radiochemical Purity, Stability and Biodistribution
Anton Larenkov et al.
MOLECULES (2019)
89Zr-Immuno-PET: Toward a Noninvasive Clinical Tool to Measure Target Engagement of Therapeutic Antibodies In Vivo
Yvonne W. S. Jauw et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Fully Automated 89Zr Labeling and Purification of Antibodies
Alex J. Poot et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
Robert L. Ferris et al.
ORAL ONCOLOGY (2018)
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer
S. J. Antonia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Copper, gallium and zirconium positron emission tomography imaging agents: The importance of metal ion speciation
Lachlan E. McInnes et al.
COORDINATION CHEMISTRY REVIEWS (2017)
A desferrioxamine B squaramide ester for the incorporation of zirconium-89 into antibodies
Stacey E. Rudd et al.
CHEMICAL COMMUNICATIONS (2016)
Competitive Adsorption of Monoclonal Antibodies and Nonionic Surfactants at Solid Hydrophobic Surfaces
Sebastian J. Kapp et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Development of a stable low-dose aglycosylated antibody formulation to minimize protein loss during intravenous administration
Sorina Morar-Mitrica et al.
MABS (2015)
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer
Julie Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The importance of using the optimal plasticware and glassware in studies involving peptides
Miriam Goebel-Stengel et al.
ANALYTICAL BIOCHEMISTRY (2011)
89Zr Radiochemistry for Positron Emission Tomography
Gregory W. Severin et al.
Medicinal Chemistry (2011)
p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging
Lars R. Perk et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine
Maria J. W. D. Vosjan et al.
NATURE PROTOCOLS (2010)
Measuring the Pharmacodynamic Effects of a Novel Hsp90 Inhibitor on HER2/neu Expression in Mice Using 89Zr-DFO-Trastuzumab
Jason P. Holland et al.
PLOS ONE (2010)
Standardized methods for the production of high specific-activity zirconium-89
Jason P. Holland et al.
NUCLEAR MEDICINE AND BIOLOGY (2009)
分享论文
